|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1999-12-10
|
|
pubmed:abstractText |
Primary radiochemotherapy is gaining increasing importance for the treatment of advanced head and neck squamous cell carcinomas. However, there is a lack of clinical factors concerning prognostic information in relation to treatment. In this pilot study, we examined whether molecular factors can provide such information.
|
|
pubmed:language |
ger
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0017-6192
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
777-86
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10525606-Adult,
pubmed-meshheading:10525606-Aged,
pubmed-meshheading:10525606-Antineoplastic Agents,
pubmed-meshheading:10525606-Carboplatin,
pubmed-meshheading:10525606-Carcinoma, Squamous Cell,
pubmed-meshheading:10525606-Cell Cycle Proteins,
pubmed-meshheading:10525606-Combined Modality Therapy,
pubmed-meshheading:10525606-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:10525606-Humans,
pubmed-meshheading:10525606-Male,
pubmed-meshheading:10525606-Middle Aged,
pubmed-meshheading:10525606-Neoplasm Staging,
pubmed-meshheading:10525606-Otorhinolaryngologic Neoplasms,
pubmed-meshheading:10525606-Pilot Projects,
pubmed-meshheading:10525606-Prognosis,
pubmed-meshheading:10525606-Radiotherapy Dosage,
pubmed-meshheading:10525606-Tumor Markers, Biological
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
[Prognostic significance of cell-cycle regulatory proteins for outcome after primary radiochemotherapy in patients with advanced head and neck cancer].
|
|
pubmed:affiliation |
Universitäts-HNO-Klinik, Heidelberg.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Multicenter Study,
Clinical Trial, Phase II
|
